Dr. Hisham Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), has launched the Regulatory AI System for Incoming Drugs (RASID) — a smart service that harnesses artificial intelligence to monitor and regulate the entry of controlled medications carried by travelers. The announcement took place during the Global Health Exhibition, held from October 27–30 at the Riyadh International Convention and Exhibition Center in Malham.
Developed by Saudi experts at the SFDA Artificial Intelligence Laboratory (SAIL), RASID marks a major leap from traditional monitoring methods to a proactive, data-driven approach that enhances drug safety and compliance.
The service streamlines the verification process for controlled medications brought by travelers, addressing previous challenges such as lengthy procedures, language barriers, and difficulties interpreting handwritten prescriptions. This innovation significantly improves the experience for visitors entering the Kingdom.
By leveraging AI, RASID automatically matches the ingredients of controlled medications with a patient’s medical condition or prescribed dosage, using medical reports or prescriptions. The system supports more than 50 languages, enabling rapid and precise verification.
RASID stands as one of the flagship outcomes of SAIL — a platform launched by the SFDA in February to develop and implement AI-powered regulatory solutions. SAIL’s mission is to drive innovation, enhance efficiency, and strengthen the SFDA’s operational and oversight capabilities.
This initiative also fosters collaboration between government bodies and technology partners to exchange expertise and build capabilities, supporting the goals of the Health Sector Transformation Program — a key pillar of Saudi Vision 2030.
Related Topics :
SFDA Reports Record 82% Surge in Licensed Factories, Warehouses in 2024
Is wheat harmful to the intestine? SFDA clarifies the truth
New Corona vaccines to arrive at the Kingdom: SFDA
SFDA: National Biotechnology Strategy Highlights Saudi Leadership in Medical Innovation
